Applied Therapeutics, Inc.

DB:2UV Stock Report

Market Cap: €1.1b

Applied Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Shoshana Shendelman

Chief executive officer

US$9.5m

Total compensation

CEO salary percentage6.6%
CEO tenure8.8yrs
CEO ownership3.9%
Management average tenureless than a year
Board average tenure7.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Shoshana Shendelman's remuneration changed compared to Applied Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$187m

Jun 30 2024n/an/a

-US$161m

Mar 31 2024n/an/a

-US$194m

Dec 31 2023US$9mUS$630k

-US$120m

Sep 30 2023n/an/a

-US$97m

Jun 30 2023n/an/a

-US$73m

Mar 31 2023n/an/a

-US$70m

Dec 31 2022US$3mUS$588k

-US$83m

Sep 30 2022n/an/a

-US$95m

Jun 30 2022n/an/a

-US$105m

Mar 31 2022n/an/a

-US$105m

Dec 31 2021US$2mUS$588k

-US$106m

Sep 30 2021n/an/a

-US$102m

Jun 30 2021n/an/a

-US$104m

Mar 31 2021n/an/a

-US$106m

Dec 31 2020US$5mUS$578k

-US$94m

Sep 30 2020n/an/a

-US$88m

Jun 30 2020n/an/a

-US$69m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$12mUS$550k

-US$46m

Sep 30 2019n/an/a

-US$35m

Jun 30 2019n/an/a

-US$28m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$1mUS$500k

-US$17m

Compensation vs Market: Shoshana's total compensation ($USD9.49M) is above average for companies of similar size in the German market ($USD1.44M).

Compensation vs Earnings: Shoshana's compensation has increased whilst the company is unprofitable.

CEO

Shoshana Shendelman (45 yo)

8.8yrs

Tenure

US$9,493,213

Compensation

Dr. Shoshana Shendelman, PhD, has been Director of Applied Therapeutics Inc. since January 2016. Prior to founding Applied, she founded Clearpoint Strategy Group, a boutique life science consulting firm, w...

Leadership Team

NamePositionTenureCompensationOwnership
Shoshana Shendelman
Chair of the Board of Directorsno dataUS$9.49m3.91%
€ 41.6m
Les Funtleyder
CFO, Principal Financial Officer & Independent Directorless than a yearUS$675.15k0.078%
€ 827.6k
Riccardo Perfetti
Chief Medical Officer6.3yrsUS$3.04m0.14%
€ 1.5m
Constantine Chinoporos
COO & Chief Business Officerless than a yearno datano data
Catherine Thorpe
Chief Accounting Officer1.4yrsno datano data
Corwin Hooks
Chief Commercial Officerless than a yearno datano data

1.0yrs

Average Tenure

57.5yo

Average Age

Experienced Management: 2UV's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Shoshana Shendelman
Chair of the Board of Directors8.8yrsUS$9.49m3.91%
€ 41.6m
Les Funtleyder
CFO, Principal Financial Officer & Independent Director8.4yrsUS$675.15k0.078%
€ 827.6k
Joel Marcus
Independent Director7.8yrsUS$85.65k0.39%
€ 4.2m
Jay Skyler
Independent Director5.6yrsUS$92.53k0.017%
€ 183.1k
Lawrence Steinman
Member of Scientific Advisory Boardno datano datano data
Teena Lerner
Lead Independent Director7.7yrsUS$88.78k0.052%
€ 553.1k
Stacy Kanter
Independent Director5.5yrsUS$94.40k0.054%
€ 576.6k
Gregg Stone
Member of Scientific Advisory Boardno datano datano data
Donald Landry
Chairman of Scientific Advisory Boardno datano datano data
Donald D'Amico
Member of Scientific Advisory Boardno datano datano data
Roy Freeman
Member of Scientific Advisory Boardno datano datano data
Roxana Mehran
Member of Scientific Advisory Boardno datano datano data

7.8yrs

Average Tenure

68yo

Average Age

Experienced Board: 2UV's board of directors are considered experienced (7.8 years average tenure).